RayzeBio is a leader in targeted radiopharmaceuticals to improving cancer patient survival. The broad pipeline of innovative drugs against solid tumor targets.


Biotechnology

RayzeBio

RayzeBio's headquarters in San Diego, CA, United States

anna Lin

yalin Zhao

Abhi Bhat

Nicholas Smith

Susan Moran

Christina Sheldahl, CPA

Eric Bischoff

Aron Knickerbocker

Daniel Gonzalez

Kevin Rosenthal

Matt Laughlin

Gary G. Li

Kimberly Ma

Hyelim Cho

Rick Corbett

Andrew Hudson

Nathan Domico

Lottie Egerson

Jessica Brown

Husnain Bokhari

Petrus R. de Jong

Yi Larson

Richard Heyman

The Research and Development Scientists at RayzeBio focus on designing and developing innovative radiopharmaceuticals tailored for targeted cancer therapy. This multidisciplinary team collaborates on drug formulation, radiochemistry, and data analytics to optimize therapeutic efficacy and safety, advancing the pipeline of treatments aimed at improving survival rates for patients with solid tumors.

Research and Development Scientists

The Healthcare Operations team at RayzeBio is responsible for overseeing the strategic implementation and management of the company’s clinical programs and operations. This team ensures seamless collaboration across departments, focusing on optimizing processes related to the development and delivery of targeted radiopharmaceuticals, while also maintaining compliance with healthcare regulations to enhance patient care in cancer treatment. Their expertise supports the efficient transition from research to clinical application, directly impacting patient outcomes and survival rates.

Healthcare Operations

The Product and Program Management team at RayzeBio oversees the strategic development and commercialization of targeted radiopharmaceuticals, ensuring alignment with the company's mission to enhance cancer patient survival. This team coordinates cross-functional collaboration, manages product pipelines, and drives program timelines, while leveraging expertise in chemistry and manufacturing to bring innovative drugs to market efficiently.

Product and Program Management

The Clinical Operations and Management team at RayzeBio oversees the planning, execution, and monitoring of clinical trials for their targeted radiopharmaceuticals. They ensure compliance with regulatory standards, coordinate with clinical sites, and manage resources to optimize trial efficiency and patient safety, ultimately driving the advancement of innovative therapies to improve cancer patient outcomes.

Clinical Operations and Management

The Leadership Team at RayzeBio is responsible for strategic decision-making and oversight of the company's operations, focusing on advancing innovative targeted radiopharmaceuticals. Comprising senior vice presidents and chief medical officers, the team drives collaboration across development, operations, and chemistry innovation to enhance the pipeline of cutting-edge treatments for solid tumors, ultimately aiming to improve patient outcomes in cancer care.

Leadership Team

The Research and Development team at RayzeBio focuses on the discovery and innovation of targeted radiopharmaceuticals for solid tumors. This interdisciplinary team, comprising experts in chemistry, biology, and clinical operations, collaborates to advance drug development from initial concept through preclinical studies, ensuring that new therapies are both effective and safe for cancer patients.

RayzeBio

Org chart

Board & advisors

Teams

Research and Development Scientists

Healthcare Operations

Product and Program Management

Clinical Operations and Management

Leadership Team

Research and Development

Offices

RayzeBio

Org chart

Board & advisors

Teams

Research and Development Scientists

Healthcare Operations

Product and Program Management

Clinical Operations and Management

Leadership Team

Research and Development

Offices

Related companies